Indeed, studies have reported that other tumors display NEK2 expression (11, 13–15); however, the mechanisms by which NEK2 controls these processes in cancer remain poorly characterized, and its role in viral lymphomas, including PEL, is unknown. The gene discussed is NEK2; the disease is cancer.